Alzheimer's disease (AD) is a prevalent neurodegenerative disorder worldwide, primarily affecting older adults. Its epidemiology reveals a rising public health concern due to aging populations globally. As of recent estimates, approximately 50 million people worldwide live with dementia, with AD contributing to 60-70% of these cases. The prevalence is projected to triple by 2050, underscoring its impact on healthcare systems and economies. AD disproportionately affects women and those with a family history of the disease. Key risk factors include age, genetic predisposition (e.g., ApoE4 allele), and lifestyle factors such as cardiovascular health. Addressing AD's epidemiology necessitates enhanced awareness, early detection strategies, and ongoing research into effective treatments and preventive measures to mitigate its growing burden on societies worldwide.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China